Cite
MLA Citation
Alessio Cortellini et al.. “Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events.” European journal of cancer, vol. 128, 2020, pp. 17–26. http://access.bl.uk/ark:/81055/vdc_100103930722.0x00002e